157 filings
Page 7 of 8
DEFA14A
31rnpzzf32cf7cwv79vj
30 Apr 19
Additional proxy soliciting materials
9:25am
DEF 14A
dbawsh5hmonw763q8nf
30 Apr 19
Definitive proxy
9:21am
S-8
8zj7ik0kfr
26 Mar 19
Registration of securities for employees
5:06pm
10-K
539gkdwpj639tljz
26 Mar 19
Annual report
5:01pm
8-K
mbs1q3
26 Mar 19
Kezar Life Sciences Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update
8:02am
8-K
c85ihxvye14amd0
6 Mar 19
Kezar Life Sciences Announces Initiation of Clinical Study to Test a New Drug Product Formulation of KZR-616
4:06pm
8-K
uwgiavd 7ro5
8 Jan 19
Departure of Directors or Certain Officers
4:05pm
8-K
30obog33 7bhtwie
7 Jan 19
Results of Operations and Financial Condition
8:00am
8-K
qpu7az8x sc
8 Nov 18
Kezar Life Sciences Reports Third Quarter 2018 Financial Results and Provides Business Update
8:05am
8-K
lbp70pjw
9 Aug 18
Kezar Life Sciences Reports Second Quarter 2018 Financial Results and Provides Business Update
4:06pm
10-Q
81nenu2nrgcwk
9 Aug 18
Quarterly report
12:00am
8-K
0vtdmco8
26 Jun 18
Amendments to Articles of Incorporation or Bylaws
5:25pm
CT ORDER
379xmo9rikbyancrjh
21 Jun 18
Confidential treatment order
9:06am
S-8
wjiliuiw
21 Jun 18
Registration of securities for employees
6:20am
424B4
to5rsph5eisb7
21 Jun 18
Prospectus supplement with pricing info
6:12am
EFFECT
62m 3r330d1by
21 Jun 18
Notice of effectiveness
12:15am
S-1MEF
0q43 rj3uhc
20 Jun 18
Registration of additional securities for an S-1
9:50pm
CERT
kiiec5if9paom4f
19 Jun 18
Certification of approval for exchange listing
4:07pm
8-A12B
zrx25c
19 Jun 18
Registration of securities on exchange
11:30am